. Author manuscript; available in PMC: 2019 Apr 2.

Published in final edited form as: J Clin Psychiatry. 2017 May;78(5):e490–e497. doi: 10.4088/JCP.15m10544

Table 1:

Participant Characteristics at Baseline across Treatment Groups^a

	EST-(n=19)	EST+(n=29)	P (t-test)	EST PHYSIOL (n=13)	EST ORAL (n=16)	P (ANOVA)
Age at Screen (Years)	19.0±0.6	20.4±0.6	0.12	21.04± 0.84	19.95±0.87	0.19
Race (%) White	90	86	0.23	77	94	0.05
Ethnicity (%) Non-Hispanic	100	97	0.41	100	94	0.36
Age of Menarche (Years)	13.4±0.4	13.7±0.5	0.66	14.5±0.6	13.1±0.6	0.16
Total Activity (Hours/week)	9.73±1.38	10.63±1.15	0.63	8.7±0.91	12.19±1.88	0.26
BMI (kg/m²)	20.7±0.5	20.5±0.4	0.83	20.70±0.60	20.35±0.64	0.90
% Ideal BMI	97.2±2.5	96.6±2.5	0.86	95.2±3.7	97.6±3.5	0.88
Weight Change over 6 Months (kg)	1.2±0.6	0.5±0.7	0.51	−0.2±1.1	1.1±0.8	0.47

Table 1 gives the participant characteristics for the EST- and EST+ group and for EST PHYSIOL and EST ORAL groups. Values are presented as Mean±SEM, if not stated otherwise. Student t test and ANOVA were used to compare the means for EST+/EST- groups and EST PHYSIOL/ESTORAL/EST- groups respectively and P values are shown.

Abbreviations: BMI=Body mass index, EST-: No estrogen replacement, EST+: Estrogen replacement, EST ORAL: Oral estrogen groups and EST PHYSIOL: Transdermal estrogen